{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:31:15Z","timestamp":1792434675788,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jad.2024.12.036","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:10:49Z","timestamp":1734005449000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine"],"prefix":"10.1016","volume":"373","author":[{"given":"Polymnia","family":"Georgiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristan A.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenessa","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd D.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.12.036_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF03346666","article-title":"Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans","volume":"33","author":"Berardelli","year":"2010","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jad.2024.12.036_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2009.141","article-title":"The CRF system, stress, depression and anxiety\u2014insights from human genetic studies","volume":"15","author":"Binder","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jocn.2020.03.005","article-title":"Neuroinflammation and depressive disorder: the role of the hypothalamus","volume":"75","author":"Cernackova","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.12.036_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.psychres.2018.09.047","article-title":"Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder","volume":"270","author":"Choi","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.12.036_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2013.10.004","article-title":"C-reactive protein and cortisol in drug-na\u00efve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease","volume":"152\u2013154","author":"Cuba\u0142a","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.12.036_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1684\/mrh.2016.0413","article-title":"Magnesium, C-reactive protein, and cortisol in drug-na\u00efve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium","volume":"29","author":"Cuba\u0142a","year":"2016","journal-title":"Magnes. Res."},{"key":"10.1016\/j.jad.2024.12.036_bb0040","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.12.036_bb0045","doi-asserted-by":"crossref","first-page":"e0215554","DOI":"10.1371\/journal.pone.0215554","article-title":"Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test","volume":"14","author":"Fitzgerald","year":"2019","journal-title":"PloS One"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2024.12.036_bb0050","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Frazer","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41593-022-01146-x","article-title":"Experimenters\u2019 sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor","volume":"25","author":"Georgiou","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jad.2024.12.036_bb0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.pnpbp.2006.01.017","article-title":"Effects of oral racemic citalopram on neuroendocrine responses","volume":"30","author":"Hawken","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jad.2024.12.036_bb0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.12.036_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41398-019-0582-7","article-title":"DNA methylation of HPA-axis genes and the onset of major depressive disorder in adolescent girls: a prospective analysis","volume":"9","author":"Humphreys","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0080","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.4088\/JCP.14m09049","article-title":"Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine","volume":"75","author":"Ionescu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0085","doi-asserted-by":"crossref","first-page":"103518","DOI":"10.1016\/j.drudis.2023.103518","article-title":"Inflammation, stress and depression: an exploration of ketamine\u2019s therapeutic profile","volume":"28","author":"Johnston","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jad.2024.12.036_bb0090","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","article-title":"Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice","volume":"6","author":"Jones","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jad.2024.12.036_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biostatistics\/kxp046","article-title":"The use of baseline covariates in crossover studies","volume":"11","author":"Kenward","year":"2010","journal-title":"Biostatistics"},{"key":"10.1016\/j.jad.2024.12.036_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/bja\/aev135","article-title":"Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion","volume":"115","author":"Khalili-Mahani","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jad.2024.12.036_bb0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0110","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jad.2024.12.036_bb0115","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2215-0366(23)00183-9","article-title":"Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies","volume":"10","author":"Medeiros","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0130","first-page":"12","article-title":"The impact of childhood maltreatment on intravenous ketamine outcomes for adult patients with treatment-resistant depression","author":"O\u2019Brien","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jad.2024.12.036_bb0135","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jad.2024.12.036_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2007.02.017","article-title":"Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment","volume":"104","author":"Papiol","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.12.036_bb0145","first-page":"393","article-title":"Effects of subanesthetic intravenous ketamine infusion on corticosterone and brain-derived neurotrophic factor in the plasma of male Sprague-Dawley rats","volume":"86","author":"Radford","year":"2018","journal-title":"AANA J."},{"key":"10.1016\/j.jad.2024.12.036_bb0150","series-title":"Dichotomania: An Obsessive Compulsive Disorder that is Badly Affecting the Quality of Analysis of Pharmaceutical Trials","author":"Senn","year":"2005"},{"key":"10.1016\/j.jad.2024.12.036_bb0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.12.036_bb0165","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00213-017-4556-2","article-title":"Don\u2019t stress about CRF: assessing the translational failures of CRF(1) antagonists","volume":"234","author":"Spierling","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jad.2024.12.036_bb0170","first-page":"802","article-title":"The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion","volume":"80","author":"Torpy","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jad.2024.12.036_bb0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1440-1681.1997.tb01213.x","article-title":"Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis","volume":"24","author":"Torpy","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jad.2024.12.036_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201cp\u00a0<\u00a00.05\u201d","volume":"73","author":"Wasserstein","year":"2019","journal-title":"Am. Stat."},{"key":"10.1016\/j.jad.2024.12.036_bb0190","doi-asserted-by":"crossref","first-page":"590221","DOI":"10.3389\/fphar.2020.590221","article-title":"Corticosterone as a potential confounding factor in delineating mechanisms underlying ketamine\u2019s rapid antidepressant actions","volume":"11","author":"Wegman-Points","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2024.12.036_bb0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0200","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.036_bb0205","article-title":"Resting-state fMRI in predicting response to treatment with SSRIs in first-episode, drug-naive patients with major depressive disorder","volume":"16","author":"Zhang","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jad.2024.12.036_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.biopsych.2011.05.018","article-title":"Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder","volume":"70","author":"Zhang","year":"2011","journal-title":"Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724020226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724020226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T04:58:20Z","timestamp":1738472300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724020226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S0165032724020226"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.12.036","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}